15.2 Fluorescein Angiography Principles, Phases & Image Interpretation
Key Takeaways
- Fluorescein absorbs blue excitation and emits longer-wavelength yellow-green light; exciter and barrier filters separate illumination from emitted signal.
- Unbound fluorescein crosses fenestrated choriocapillaris but normally remains within nonfenestrated retinal capillaries protected by endothelial tight junctions.
- Arm-to-retina time and phase timing vary with injection site, cardiac output, circulation, device, and protocol, so record actual elapsed time rather than treating one range as universal.
- Leakage expands and blurs, pooling fills an anatomic space, staining increases tissue fluorescence without expansion, and a transmission defect reveals background fluorescence through reduced pigment.
- Autofluorescence and pseudofluorescence are pre-injection phenomena or artifacts, not a fifth mechanism of fluorescein dye hyperfluorescence.
Fluorescein Angiography: Principles, Phases, and Patterns
Fluorescein angiography is a timed record of dye moving through ocular circulation. The technician produces a complete, correctly timed sequence and monitors safety. The clinician interprets the pattern with examination and other imaging.
Optical and vascular principles
Sodium fluorescein absorbs blue light and emits yellow-green light at a longer wavelength. An exciter filter selects incoming blue light; a barrier filter blocks reflected excitation and passes emitted fluorescence. Filter mismatch, gain, media opacity, and focus can create misleading brightness.
Most circulating dye is protein-bound; the unbound portion fluoresces and can pass through fenestrated choriocapillaris into choroidal tissue. Retinal capillary endothelial tight junctions form the inner blood-retinal barrier and normally retain dye. RPE tight junctions contribute to the outer barrier and pigment masks much choroidal fluorescence.
Safety and preparation
Verify patient, order, study eye or eyes, dye, dose and route, prior reaction, IV status, and emergency readiness. Explain transient skin or urine discoloration and possible nausea according to the approved patient information. Stop and escalate urticaria with progression, respiratory symptoms, hypotension, severe extravasation pain, or another systemic reaction.
Obtain baseline color or red-free images if ordered. Focus, center, set field, and practice fixation before injection because the earliest frames cannot be recreated.
Acquisition sequence
Start the timer at the protocol-defined injection point. Capture the requested eye and field during choroidal flush, arterial filling, arteriovenous transit, venous filling, recirculation, and late frames. Exact seconds vary with injection site, cardiovascular status, circulation, device, and protocol. Record the observed arrival time rather than declaring a fixed normal from memory.
Use the fellow eye and steered fields as ordered. Late images are important for leakage, staining, and pooling. Note motion, blink, focus, media opacity, missed frames, infiltration, or altered injection so the interpreter understands limitations.
Increasing fluorescence
- Leakage: fluorescence increases in intensity and spreads beyond original borders with increasing blur.
- Pooling: dye accumulates within a defined anatomic space and respects its borders.
- Staining: tissue retains dye and becomes brighter without progressive expansion, such as a scar or disc tissue pattern.
- Transmission or window defect: reduced pigment permits background choroidal fluorescence to show through; borders usually correspond to the area of pigment loss without leakage.
Autofluorescence is present before dye injection, and pseudofluorescence can result from imperfect filter separation. Compare pre-injection frames before calling either a dye mechanism.
Reduced fluorescence
Blocked fluorescence occurs when blood, pigment, exudate, media opacity, or another material obscures otherwise fluorescent structures. Filling defect or nonperfusion reflects absent or delayed dye within a vessel or capillary bed. The distinction depends on color images, location, phase behavior, and other imaging.
Quality and role boundaries
Keep magnification, field, focus, gain, and timing comparable with prior studies when possible. Avoid clipping bright areas. Save original frames and metadata. Do not delete a poor but clinically relevant early sequence; label the limitation and add repeat or alternative frames if authorized.
Technicians may recognize that a pattern needs rapid attention, but they should not tell the patient that angiography proves neovascularization, occlusion, or treatment need. Route the study promptly.
| Observation | Acquisition clue | Interpretation caution |
|---|---|---|
| Expanding blurred brightness | Compare serial early and late frames | Supports leakage, but disease context matters |
| Fixed-border filling of a space | Capture through late phase | Supports pooling |
| Darkness under hemorrhage | Compare color photograph | May be blockage, not nonperfusion |
| Delayed vessel filling | Preserve accurate timer | Systemic circulation and injection affect timing |
The strongest study combines safe dye administration, disciplined timing, complete fields, and honest artifact documentation.
Safety checks and image-quality controls
Before injection, verify two identifiers, order, eye and fields, product, dose and route, expiration, venous access, pregnancy status when relevant, prior reactions, and emergency readiness. Nausea and warmth can be self-limited, but hives, breathing difficulty, hypotension, facial or tongue swelling, or collapse requires stopping administration and activating the emergency response. A negative allergy history does not eliminate risk.
Focus and center before injection, establish a synchronized timer, and acquire the ordered early sequence without sacrificing safety. Record actual elapsed time because circulation varies. In later phases, reproduce field and focus so apparent change is not just framing. Label missed frames, motion, blink, media opacity, leakage obscuring detail, or extravasation. Hyperfluorescence is described by pattern and temporal behavior; the technician does not diagnose choroidal neovascularization or decide treatment. Hypofluorescence may reflect blocked fluorescence or nonperfusion, and those mechanisms require clinical interpretation with the color image and other modalities.
Which fluorescein pattern grows in size and becomes less sharply bordered in late frames?
Why can fluorescein enter choroidal tissue while remaining within normal retinal capillaries?
How should the technician handle an arm-to-retina time outside a memorized range?